Prognostic impact of the glypican family of heparan sulfate proteoglycans on the survival of breast cancer patients.
Paulina Karin GrilloGyorffy BalazsMartin GöttePublished in: Journal of cancer research and clinical oncology (2021)
Our study concludes that glypicans could act as subtype-specific biomarkers for the prognosis of breast cancer patients and sparks hope for future research on glypicans possibly eventually providing targets for the treatment of the disease.
Keyphrases